AP
Aspen Pharmacare
APN.JO·JSEDurban ZAFounded 18509,000 employees
Mid CappharmaPublicHematologyInfectious Disease
Platform: Specialty Sterile
Market Cap
$6B
All Drugs
4
Clinical Trials
5
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (APN.JO)
Loading APN.JO stock data...
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| APN-6857 | APN-6857 | Phase 2 | 1 | GPRC5D | MCCUC | ||
| APN-1617 | APN-1617 | Phase 2 | 1 | PLK4 | NSCLCHuntington's | ||
| APN-2677 | APN-2677 | NDA/BLA | 1 | FcRn | MCCSCLC | ||
| APN-7734 | APN-7734 | Phase 1 | 2 | CDK4/6 | DLBCLRett |
SEC Filings & Financial Documents
SEC filings are not available for JSE-listed companies.
Aspen Pharmacare trades on JSE (ZA). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (4)